Drug Development Technology 5 septembre 2018 Abivax reports positive topline results from ABX464-101 trial for UC
IBD News Today 5 septembre 2018 Investigational ABX464 Enhances Remission Rates, Mucosal Healing in Ulcerative Colitis Patients in Phase 2a Trial
